What Do You See
Management of DM in Patients With CKD
- Monitor for changes in BP, serum creatinine, & serum K+ within 2–4 weeks of initiation or increase in the dose of an ACEi or ARB.
- Continue ACEi or ARB therapy unless serum creatinine rises by > 30% within 4 weeks following initiation of treatment or an increase in dose.
- FDA recommends, metformin should NOT be used with serum creatinine ≥ 1.5 mg/dl in men & ≥ 1.4 mg/dl in women or with decreased creatinine clearance in people > 80.
- Recommended is treating patients with T2D, CKD, & an eGFR ≥ 30 ml/min per 1.73 m2 with metformin.
ADA/KDIGO Consensus Statements:
Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS)
Myocardial Infarction:
Classified into 5 types based on etiology and circumstances:
- Type 1: Spontaneous MI caused by ischemia due to a primary coronary event (eg, plaque rupture, erosion, or fissuring; coronary dissection).
- Type 2: Ischemia due to increased oxygen demand (eg, hypertension), or decreased supply (eg, coronary artery spasm or embolism, arrhythmia, hypotension).
- Type 3: Related to sudden unexpected cardiac death.
- Type 4a: Associated with percutaneous coronary intervention (signs and symptoms of myocardial infarction with cTn values > 5 × 99th percentile URL).
- Type 4b: Associated with documented stent thrombosis.
- Type 5: Associated with coronary artery bypass grafting (signs and symptoms of myocardial infarction with cTn values > 10 × 99th percentile URL).
Infarct location
- Right ventricular infarction usually results from obstruction of the right coronary or a dominant left circumflex artery; it is characterized by high RV filling pressure, often with severe tricuspid regurgitation and reduced cardiac output.
- An inferoposterior infarction causes some degree of RV dysfunction in about half of patients and causes hemodynamic abnormality in 10 to 15%. RV dysfunction should be considered in any patient who has inferoposterior infarction and elevated jugular venous pressure with hypotension or shock. RV infarction complicating LV infarction significantly increases mortality risk.
- Anterior infarcts tend to be larger and result in a worse prognosis than inferoposterior infarcts. They are usually due to left coronary artery obstruction, especially in the anterior descending artery; inferoposterior infarcts reflect right coronary or dominant left circumflex artery obstruction.
Acute Cholangitis
Pseudo- Conditions in Medicine
Acute Pulmonary Embolism
Thyroid storm
- Therapy to control increased adrenergic tone: Beta-blocker
- Therapy to reduce thyroid hormone synthesis: Thionamide
- Therapy to reduce the release of thyroid hormone: Iodine solution
- Therapy to block peripheral conversion of T4 to T3: Iodinated radiocontrast agent, glucocorticoid, PTU, propranolol
- Therapy to reduce enterohepatic recycling of thyroid hormone: Bile acid sequestrant
Urinalysis & Urine Sodium
- [(U Na x P Cr) / (P Na x U Cr)] x 100
- U = Urine, P = Plasma, Cr = Creatinine, Na = Sodium.
- Re-absorption and filtration accounted (Both).
- Should not be used with normal renal function.
- FE Na < 1%
- Urine sodium < 20 mEq/L.
- FE Na > 2%
- Urine sodium > 40 mEq/L.
Capnography
- Provides a measure of ventilation – or concentration of CO2 exhaled air
- (aka end tidal CO2 or etCO2).
- Not effected by supplemental oxygen.
- Reflects breath-to-breath ventilation.
- Appear not normal if the patient has stopped breathing.
- Apnea or hypoventilation is detected immediately by capnography
- Measures oxygenation or arterial blood oxygen saturation & pulse rate.
- Detects oxygen deficiency (hypoxia).
- May appear normal even if the patient has stopped breathing.
- Takes time to detect Apnea or hypoventilation.
Hypoglycemia
Kidney disease: insulin not cleared out of circulation well.
Medications for Diabetic.
More frequently:
Meglitinides,
Sulfonylureas,
Insulin
Very infrequently:
Metformin,
GLP-receptor agonists,
SGLT-2, and
DPP-4 inhibitor
Liver Abscess
- Pyogenic abscess, accounts for 80% of abscess.
- Amebic abscess due to Entamoeba histolytica, accounts for 10%.
- Fungal abscess, accounts for < 10%.
- 50% of solitary liver abscesses occur in the right Liver lobe.
- Right hepatic lobe (~75%), less commonly left (20%) or caudate (5%) lobes.
- Pyogenic abscesses are usually polymicrobial.
- 50% of the bacterial cases develop by cholangitis.
- Pyogenic Abscess- initial manifestation of an occult intra‐abdominal malignancy (up to 15%).
- Positive blood cultures in up to 50%.
- Most common organisms: E. coli, Klebsiella, Streptococcus, Staphylococcus, & anaerobes.
- K pneumoniae thought to be associated with colorectal cancer.
- Fever in 90% & abdominal pain in about 50-75%.
- In-hospital mortality estimated at 2.5% -19%
Drainage of the abscess & antibiotic treatment are the cornerstones of treatment.
- Antibiotic Therapy:
Oral antibiotics are given after intravenous antibiotics are first administered.
- Percutaneous Drainage:
Continuous fever despite 48-72 hours of ABX therapy
Indications that the abscess may rupture
U/S or CT-guided aspiration & drainage- first-line treatment.
- Surgery:
When there are complications like rupture or numerous abscesses.
Open surgery or laparoscopic surgery.
Electrolyte Replacement
Significant electrolyte depletion can result in serious complications. These guidelines are meant to assist with empiric dosing of electrolytes for inpatients. Doses may need to be adjusted based on patient-specific factors, including creatine & cardiac status; & responses to initial doses.
- Goal serum potassium concentration 4.0 – 5.0 mEq/L
- Goal serum ionized calcium concentration 1.12 – 1.3 mmol/L
- Goal serum magnesium concentration 2.0 – 2.4 mg/dL
- Goal serum phosphorus concentration 2.7 – 4.6 mg/dL
IV electrolyte replacement can produce life-threatening complications, serious arrhythmias & phlebitis; therefore, supplementation must be carefully monitored. There are multiple underlying factors for electrolyte disorders in adult inpatients, including alterations in absorption, distribution, hormonal, and/or homeostatic mechanisms that can all cause disturbances. Treating the underlying cause and prescribing adequate therapy is essential for repletion. In addition, the intracellular vs. extracellular electrolyte concentrations must be considered. Due to distribution variances, labs may not directly correlate with true electrolyte levels. Therefore, continuous monitoring is essential to properly replete patients.